What ReMedys does – Who we are...


The ReMedys Board monitors the running of the foundation, the distribution of ReMedys’ resources and the projects managed under the ReMedys umbrella.

The board consists of experienced professionals from different business areas to ensure that all foundation business and our diverse project portfolio is competently assessed and supervised.

Dr. Michel Dreano

ReMedys Founder and Board Member

Dr. Dreano graduated from the University of Burgundy (PhD in Cell Biology) and from the University Paris 7/Institute Pasteur, France (PhD in Microbiology). He brings to the ReMedys more than 25 years professional experience in biotechnology and pharmaceuticals industry.

He recently established M3DC an independent consulting company. He has actively participated in the development of various drug candidates (small molecules and biologics) that have progressed up to clinical evaluation. These achievements were conducted in collaborations with renowned researchers worldwide in a number of therapeutic fields including neurology, oncology, endocrinology, arthritis, and nanotechnology. His work has led to the publication of numerous peer-reviewed articles and 10 patent families. Dr. Dreano is also the co-founder of Relief Therapeutics S.A. and has his own consulting company M3DC Sàrl. Dr. Dreano is specializing in the planning and execution of global multi-partner alliances involving industrial and academic partners for preclinical and clinical projects. This includes management of budget, timelines, resource allocation, follow up and reporting, thus securing professional management for ReMedys’ drug development project portfolio.